Educational lectures from international speaker as well as in-depth discussion with our local key expert for chronic myeloid leukemia (CML) management with the addition of new class of drug, STAMP inhibitors for early lines. This learning from international and local expert can help to elevate the CML management to improve patient care.
The Malaysian Society of Haematology (MSH) is pleased to share that abstract submissions are now open for the 6th Annual Scientific Meeting of the Association for Haemophilia and Allied Disorders – Asia Pacific (AHAD-AP).
This meeting provides an excellent opportunity for healthcare professionals involved in haemophilia and inherited bleeding disorders to showcase their research, clinical experience, quality improvement initiatives, and multidisciplinary care projects on a regional platform.
We warmly encourage colleagues from Malaysia and across the Asia-Pacific region to consider submitting their work and contributing to the advancement of haemophilia care.
Please refer to the poster below for submission details and further information.